- Deal Activity Slows for Asset-Based Lending, but Portfolio Performance Stays Strong
- Exploring the Future of Supply Chain Finance: Insights from SFNet's Inaugural Conference
- Navigating 2025: SFNet’s Asset-Based Capital Conference Returns to Las Vegas with Premier Insights and Networking
- Siena Lending Group Announces Leadership Transition Plan
- Celebrating the Achievements of SFNet Chapters
Huntington Business Credit Closes Credit Facility with Spirit Pharmaceuticals, LLC
August 8, 2022
By Huntington Business Credit
Huntington Business Credit announced it closed a $20,000,000 new credit facility with Spirit Pharmaceuticals, LLC on July 6, 2022. Proceeds of the facility were used to refinance existing indebtedness and provide ongoing working capital growth financing.
Spirit Pharmaceuticals, LLC, headquartered in Ronkonkoma, New York, is a packager and wholesaler of private label over the counter (“OTC”) pharmaceutical products.
Huntington Business Credit provides working capital and term loan facilities to middle market companies for acquisitions, LBO’s, MBO’s recapitalizations, rapid growth, seasonal working capital build-up, and turnaround situations.